Table 4 Pathogens doctors believed to be included in routine stool MCS investigations
From: Diagnostic testing practices for diarrhoeal cases in South African public hospitals
Total (n = 32) | Urban site (n = 10) | Rural sites (n = 22) | p-value | |
|---|---|---|---|---|
Bacteria | ||||
Salmonella spp. | 27 (84.4%) | 10 (100.0%) | 17 (77.3%) | 0.155 |
Shigella spp. | 27 (84.4%) | 10 (100.0%) | 17 (77.3%) | 0.155 |
EHEC | 17 (53.1%) | 4 (40.0%) | 13 (59.1%) | 0.316 |
Campylobacter spp. | 13 (40.6%) | 4 (40.0%) | 9 (40.9%) | > 0.999 |
All Shiga toxin-producing E. coli (STEC) | 13 (40.6%) | 5 (50.0%) | 8 (36.4%) | 0.699 |
C. difficile | 11 (34.4%) | 4 (40.0%) | 7 (31.8%) | 0.703 |
All diarrhoeagenic E. coli | 9 (28.1%) | 4 (40.0%) | 5 (22.7%) | 0.407 |
Vibrio spp. | 4 (12.5%) | 0 (0.0%) | 4 (18.2%) | 0.283 |
Yersinia enterocolitica | 3 (9.4%) | 1 (10.0%) | 2 (9.1%) | > 0.999 |
Parasites | ||||
Giardia lamblia | 16 (50.0%) | 4 (40.0%) | 12 (54.6%) | 0.704 |
Cryptosporidium spp. | 10 (31.3%) | 3 (30.0%) | 7 (31.8%) | < 0.999 |
Cystoisospora spp. | 9 (28.1%) | 3 (30.0%) | 6 (27.3%) | < 0.999 |
Entamoeba histolytica | 9 (28.1%) | 2 (20.0%) | 7 (31.8%) | 0.681 |
Microsporidia spp. | 5 (15.6%) | 2 (20.0%) | 3 (13.6%) | 0.637 |
Cyclospora spp. | 2 (6.3%) | 2 (20.0%) | 0 (0.0%) | 0.091 |
Aeromonas spp. | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | – |
Viruses | ||||
Rotavirus | 12 (37.5%) | 2 (20.0%) | 10 (45.5%) | 0.248 |
Adenovirus | 12 (37.5%) | 2 (20.0%) | 10 (45.5%) | 0.248 |
Norovirus | 5 (15.6%) | 1 (10.0%) | 4 (18.2%) | > 0.999 |